Maple Securities USA’s Bausch Health BHC Stock Holding History

Maple Securities USA’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,044	Closed	-$406K	–	243
2015 Q1	$406K	Buy	+2,044	New	+$363K	0.03%	131

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Maple Securities USA's BHC Position: Q2 2015 in Review

Maple Securities USA sold out of Bausch Health (BHC) in Q2 2015, closing a stake of 2,044 shares — an estimated $406K sold.

Maple Securities USA first reported a position in BHC in Q1 2015 and held it in 1 quarter. The position peaked at $406K in Q1 2015. 582 funds tracked by Wall St. Rank hold BHC as of Q2 2015.

Maple Securities USA reported no remaining Bausch Health position as of Q2 2015 after selling out during the quarter.
Maple Securities USA sold 2,044 Bausch Health shares in Q2 2015, an estimated $406K.
Maple Securities USA first reported a position in Bausch Health in Q1 2015 and held it in 1 quarter.
Maple Securities USA's Bausch Health position peaked at $406K in Q1 2015.
582 funds tracked by Wall St. Rank held Bausch Health as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.